EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
1.960
-0.190 (-8.84%)
At close: Mar 31, 2025, 4:00 PM
1.980
+0.020 (1.02%)
After-hours: Mar 31, 2025, 5:01 PM EDT
EDAP TMS Market Cap
EDAP TMS has a market cap or net worth of $72.72 million as of March 31, 2025. Its market cap has decreased by -73.92% in one year.
Market Cap
72.72M
Enterprise Value
56.25M
1-Year Change
-73.92%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since December 31, 2001, EDAP TMS's market cap has increased from $17.50M to $72.72M, an increase of 315.56%. That is a compound annual growth rate of 6.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 80.30M | -2.43% |
Dec 31, 2024 | 82.30M | -57.88% |
Dec 29, 2023 | 195.40M | -45.60% |
Dec 30, 2022 | 359.20M | 86.11% |
Dec 31, 2021 | 193.00M | 28.07% |
Dec 31, 2020 | 150.70M | 17.28% |
Dec 31, 2019 | 128.50M | 139.74% |
Dec 31, 2018 | 53.60M | -34.95% |
Dec 29, 2017 | 82.40M | -1.08% |
Dec 30, 2016 | 83.30M | -18.89% |
Dec 31, 2015 | 102.70M | 102.17% |
Dec 31, 2014 | 50.80M | -6.27% |
Dec 31, 2013 | 54.20M | 99.26% |
Dec 31, 2012 | 27.20M | 23.64% |
Dec 30, 2011 | 22.00M | -64.23% |
Dec 31, 2010 | 61.50M | 132.95% |
Dec 31, 2009 | 26.40M | 100.00% |
Dec 31, 2008 | 13.20M | -68.79% |
Dec 31, 2007 | 42.30M | -7.44% |
Dec 29, 2006 | 45.70M | 4.10% |
Dec 30, 2005 | 43.90M | 48.31% |
Dec 31, 2004 | 29.60M | 112.95% |
Dec 31, 2003 | 13.90M | 49.46% |
Dec 31, 2002 | 9.30M | -46.86% |
Dec 31, 2001 | 17.50M | - |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 736.92B |
UnitedHealth Group | 481.29B |
Johnson & Johnson | 399.61B |
AbbVie | 370.37B |
Novo Nordisk | 305.46B |
Abbott Laboratories | 229.87B |
AstraZeneca | 225.46B |
Merck & Co. | 225.25B |